Why Canopy Growth (TSX:WEED) Stock Is Beating Aurora Cannabis (TSX:ACB)

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) stock is falling behind its main rival. Here’s why.

| More on:
Cannabis stocks have fallen.

Last week, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) went on an epic bull run, rising 14.95% in the span of just five days. This came after an earnings report that topped revenue expectations and showed diluted per-share losses getting smaller. While the quarter was hardly a stunning success, it beat investor expectations enough to send WEED shares soaring.

Around the same time, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) delivered an earnings report of its own–this one disappointing by virtually every metric.

With revenue declines in every single business segment and a massive $1.3 billion net loss, it was not well received by the financial press. ACB still rose 5% last week, as the market had apparently been pricing the shares for even worse results.

Nevertheless, we’ve got Canopy decisively beating Aurora post-earnings, which begs the question, why? Just a few months ago, Canopy was making headlines for its own $1 billion plus losses and high-profile executive firings.

Now Aurora is in the exact same boat. To understand how this happened, we need to take a closer look at both companies’ recent earnings.

Better earnings results

Canopy’s Q3 earnings were better than Aurora’s by almost every metric. Canopy’s revenue grew in Q3, both year over year and sequentially. Aurora’s declined sequentially, with a 26% overall decline, which came from lower sales in every single business segment.

Additionally, Canopy’s loss got smaller on a diluted per share basis, while Aurora’s got larger. In Q3, Canopy lost $0.35 per diluted share, compared to $0.38 in the same quarter a year before. Aurora, on the other hand, lost $1.18 per share compared to $0.25 in the prior year quarter.

The biggest reason for Aurora’s massive loss was goodwill impairment. The company had a whopping $800 million impairment charge thrown at it, resulting in a huge hit to both the balance sheet and income statement.

This had no impact on cash flows, so the company’s reported $80 million adjusted EBITDA loss may be more instructive. Nevertheless, it was a big and very well publicized hit.

News coverage

Speaking of publicity, Aurora has been getting a great deal of it lately–most of it negative.

Last year, the company had its license to sell cannabis in Germany suspended. Shortly after that, it was reported that the company sold a cannabis facility for $17 million, losing money on the deal.

Finally, the company’s CEO Terry Booth stepped down. Taken together, these stories don’t paint a picture of a thriving company. Granted, Canopy was in a very similar boat around the middle of last year, and it bounced back, but it looks like Aurora’s woes have come at an inopportune time.

Foolish takeaway

Despite everything I’ve written about Canopy and Aurora in this article, I wouldn’t decisively recommend one stock over the other. As mentioned above, the difficulties Aurora is going through now are similar to ones Canopy went through last year.

It’s quite possible that Aurora will get over the slump it’s in now and come back bigger and better. For now, though, it’s undeniably falling behind its main rival.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »